PostEra

PostEra

A biotechnology company using machine learning for medicinal chemistry services.

PostEra is a biotechnology company using machine learning for medicinal chemistry services that is headquartered in Santa Clara, California and was founded in 2019 by Aaron Morris, Alpha Lee, and Matt Robinson. The company's machine learning algorithms can help design and optimize chemical compounds by exploring new chemical possibilities and optimizing existing scaffolds. PostEra Claims their software tools were the first to beat humans at chemical reaction prediction. Customers of PostEra are able to use their platform to order new chemical compounds.

PostEra has published scientific studies in collaboration with Pfizer to predict bioactivity with low-data limits to improve the performance of prospective experiments by two fold. Another collaborative study with Pfizer showed that PostEra's prediction algorithms are generalizable to the pharmaceutical chemical industry and can predict synthetic pathways to create drug-like molecules.

Funding
Pre-seed

On March 16, 2020 PostEra announced raising $150,000 in pre-seed funding from Y Combinator.

Seed

On March 30, 2020 PostEra announced raising $2.3 million in seed funding from undisclosed investors.

Timeline

November 25, 2020
PostEra announces a collaboration with NeuroLucent, a Chicago-based company focused on developing novel treatments for Alzheimer's disease and other dementias.
March 30, 2020
PostEra raises a $2,300,000 seed round.
March 16, 2020
PostEra raises a $150,000 seed round from Y Combinator.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
PostEra pre-seed round
150,000
March 16, 2020
2,300,000
March 30, 2020
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
PostEra
December 8, 2020
www.prnewswire.com:443
/PRNewswire/ -- PostEra, ein auf maschinelle Lernlösungen für die präklinische Arzneimittelforschung spezialisiertes Biotechnologieunternehmen, gab heute eine...
PostEra
December 8, 2020
www.prnewswire.com:443
/PRNewswire/ -- A PostEra, uma empresa de biotecnologia especializada em soluções de aprendizado de máquina para a descoberta de medicamentos pré-clínicos,...
PostEra
December 8, 2020
www.prnewswire.com:443
/PRNewswire/ -- PostEra, una empresa de biotecnología que se especializa en soluciones de aprendizaje automático para el descubrimiento de fármacos...
PostEra
December 8, 2020
www.prnewswire.com:443
/PRNewswire/ -- PostEra, une société de biotechnologie spécialisée dans les solutions d'apprentissage automatique pour la recherche pharmaceutique préclinique,...
PostEra
December 7, 2020
www.prnewswire.com:443
/PRNewswire/ -- PostEra, una compañía de biotecnología especializada en soluciones de aprendizaje de máquina para descubrimiento de fármacos preclínico, ha...
PostEra
November 26, 2020
www.prnewswire.com:443
/PRNewswire/ -- PostEra, ein Biotechnologieunternehmen, das Medizinalchemie über maschinelles Lernen anbietet, hat heute seine Zusammenarbeit mit NeuroLucent...
PostEra
November 26, 2020
www.prnewswire.com:443
/PRNewswire/ -- PostEra, une société de biotechnologie proposant de la chimie thérapeutique alimentée par l'apprentissage automatique, a annoncé aujourd'hui...
PostEra
November 26, 2020
www.prnewswire.com:443
/PRNewswire/ -- PostEra, una empresa de biotecnología que ofrece química medicinal impulsada por el aprendizaje automático, anunció hoy una colaboración con...
BioSpace
November 25, 2020
BioSpace
PostEra, a biotechnology company offering medicinal chemistry powered by machine learning, today announced a collaboration with NeuroLucent, a Chicago-based company focused on developing novel treatments for Alzheimer's disease and other dementias.
PostEra
November 25, 2020
www.prnewswire.com:443
/PRNewswire/ -- PostEra, a biotechnology company offering medicinal chemistry powered by machine learning, today announced a collaboration with NeuroLucent, a...
Greg Kumparak
March 17, 2020
TechCrunch
With YC's W20 Demo Day coming in at nearly 200 companies, we've decided to split our recap into multiple posts for easier reading. These are the hardware, AI/ML, and developer-focused companies

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.